CONTINUUM: Lifelong Learning in Neurology:
doi: 10.1212/01.CON.0000429186.90589.7e
Table of Contents

Table of Contents

Free Access

Guest Editor: Claudia Kawas, MD

Editor’s Preface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .323

Back to Top | Article Outline

REVIEW ARTICLES

Biomarkers of Alzheimer Disease: Current and Future Applications to Diagnostic Criteria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .325

Reisa Sperling, MD; Keith Johnson, MD

Alzheimer Disease Pharmacologic Treatment and Treatment Research . . . . . .339

Lon S. Schneider, MD, MS

New Genes and New Insights from Old Genes: Update on Alzheimer Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .358

John M. Ringman, MD, MS; Giovanni Coppola, MD

Nonpharmacologic Treatment and Prevention Strategies for Dementia . . . .372

Kristine Yaffe, MD; Tina Hoang, MSPH

The Clinical Problem of Neuropsychiatric Signs and Symptoms in Dementia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .382

Anna Burke, MD; Geri Hall, PhD, ARNP, GCNS, FAAN; Pierre N. Tariot, MD

The Diagnostic Evaluation of a Patient With Dementia . . . . . . . . . . . . . . . . . . .397

Douglas Galasko, MBBCh

Mild Cognitive Impairment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .411

Oscar L. Lopez, MD

Understanding and Treating Vascular Cognitive Impairment . . . . . . . . . . . . .425

Philip B. Gorelick, MD, MPH, FAAN; David Nyenhuis, PhD, ABPP

Incorporating New Diagnostic Schemas, Genetics, and Proteinopathy into the Evaluation of Frontotemporal Degeneration . . . . . . . . . . . . . . . . . . . .438

Tiffany W. Chow, MD; Ammar A. Alobaidy, MD

Dementia in the Oldest Old . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .457

Szófia S. Bullain, MD; María M. Corrada, ScM, ScD

Back to Top | Article Outline

ETHICAL PERSPECTIVES

“Will I Get Alzheimer Disease?” When Cognitively Normal Patients Ask to be Tested for Alzheimer Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .470

B. Joy Snider, MD, PhD; Virginia D. Buckles, PhD

Back to Top | Article Outline

PRACTICE ISSUES

Genetic Testing for Early-Onset Alzheimer Disease . . . . . . . . . . . . . . . . . . . . . .475

Jack W. Tsao, MD, DPhil, FAAN

Coding for Behavioral Neurology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .480

John Hart Jr, MD; Kyle B. Womack, MD; Laura B. Powers, MD, FAAN; Marc R. Nuwer, MD, PhD, FAAN

Back to Top | Article Outline

SELF-ASSESSMENT AND CME

Learning Objectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .315

Instructions for Completing the Self-Assessment Pretest and Tally Sheet . . . . . .317

Self-Assessment Pretest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .319

Instructions for Completing CME and Tally Sheet . . . . . . . . . . . . . . . . . . . . . . . .491

Multiple-Choice Questions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .493

Multiple-Choice Questions—Preferred Responses . . . . . . . . . . . . . . . . . . . . . . .503

Patient Management Problem . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .519

Patient Management Problem—Preferred Responses . . . . . . . . . . . . . . . . . . . .525

Aimee Pierce, MD

Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .538

List of Abbreviations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Back Cover

© 2013 American Academy of Neurology

Login